ConductScience.org, home

Paper1664645

Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro.

Lakkakorpi PT and 1 other. J Bone Miner Res, 1991. Cited by 206 papers, by iCite.

Cite this record

ConductScience Library. Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro. Papers, record 1664645. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1664645

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro.
PubMed
Journal
J Bone Miner Res
PubMed
Year
1991
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
206
iCite
Relative citation ratio, by iCite
4.81
iCite
Revised in PubMed
2018-11-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lakkakorpi PTP T
2Väänänen HKH K

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Actin CytoskeletonMajor topic
Bone ResorptionMajor topic
BucladesineMajor topic
MicrotubulesMajor topic
OsteoclastsMajor topic
Actins
Animals
Cells, Cultured
Fluorescent Antibody Technique
Kinetics
Polyethylene Glycols
Rats
Talin
Vinculin

Source PubMed

Download CSV of topics

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 206 citations.

PMIDTitleJournalYearIn PapersSource
41235741The Role of Runx2 in Microtubule Dynamics and Its Effects on Osteoblast Migration.Cytoskeleton (Hoboken)2026https://conductscience.org/library/papers/41235741PubMed
40429901Formation of Membrane Domains via Actin Waves: A Fundamental Principle in the Generation of Dynamic Structures in Phagocytes.Int J Mol Sci2025https://conductscience.org/library/papers/40429901PubMed
39871069Kurarinone Mitigates LPS-Induced Inflammatory Osteolysis by Inhibiting Osteoclastogenesis Through the Reduction of ROS Levels and Suppression of the PI3K/AKT Signaling Pathway.Inflammation2025https://conductscience.org/library/papers/39871069PubMed
39649800Vav family exchange factors: Potential regulator in atherosclerosis.Biochem Biophys Rep2024https://conductscience.org/library/papers/39649800PubMed
38675559A 70% Ethanol Neorhodomela munita Extract Attenuates RANKL-Induced Osteoclast Activation and H2O2-Induced Osteoblast Apoptosis In Vitro.Molecules2024https://conductscience.org/library/papers/38675559PubMed
38203618Collagen-like Osteoclast-Associated Receptor (OSCAR)-Binding Motifs Show a Co-Stimulatory Effect on Osteoclastogenesis in a Peptide Hydrogel System.Int J Mol Sci2023https://conductscience.org/library/papers/38203618PubMed
37988238Sesamin inhibits RANKL-induced osteoclastogenesis and attenuates LPS-induced osteolysis via suppression of ERK and NF-κB signalling pathways.J Cell Mol Med2024https://conductscience.org/library/papers/37988238PubMed
37380172Convergence of Calcium Channel Regulation and Mechanotransduction in Skeletal Regenerative Biomaterial Design.Adv Healthc Mater2023https://conductscience.org/library/papers/37380172PubMed
37111558Physicochemical, Pre-Clinical, and Biological Evaluation of Viscosity Optimized Sodium Iodide-Incorporated Paste.Pharmaceutics2023https://conductscience.org/library/papers/37111558PubMed
36408264Norcantharidin ameliorates estrogen deficient-mediated bone loss by attenuating the activation of extracellular signal-regulated kinase/ROS/NLRP3 inflammasome signaling.Front Pharmacol2022https://conductscience.org/library/papers/36408264PubMed
35718926Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis.J Bone Metab2022https://conductscience.org/library/papers/35718926PubMed
34576260Plasma Membrane Receptors Involved in the Binding and Response of Osteoclasts to Noncellular Components of the Bone.Int J Mol Sci2021https://conductscience.org/library/papers/34576260PubMed
33859985The Mechanism Switching the Osteoclast From Short to Long Duration Bone Resorption.Front Cell Dev Biol2021https://conductscience.org/library/papers/33859985PubMed
32824687Osteoclasts' Ability to Generate Trenches Rather Than Pits Depends on High Levels of Active Cathepsin K and Efficient Clearance of Resorption Products.Int J Mol Sci2020https://conductscience.org/library/papers/32824687PubMed
31346562Profilin 1 Negatively Regulates Osteoclast Migration in Postnatal Skeletal Growth, Remodeling, and Homeostasis in Mice.JBMR Plus2019https://conductscience.org/library/papers/31346562PubMed
31181716Osteoclast-Released Wnt-10b Underlies Cinacalcet Related Bone Improvement in Chronic Kidney Disease.Int J Mol Sci2019https://conductscience.org/library/papers/31181716PubMed
30634501Specialized Roles for Actin in Osteoclasts: Unanswered Questions and Therapeutic Opportunities.Biomolecules2019https://conductscience.org/library/papers/30634501PubMed
30244178L-plastin phosphorylation regulates the early phase of sealing ring formation by actin bundling process in mouse osteoclasts.Exp Cell Res2018https://conductscience.org/library/papers/30244178PubMed
29526830Inhibition of osteoclastogenesis by stem cell-derived extracellular matrix through modulation of intracellular reactive oxygen species.Acta Biomater2018https://conductscience.org/library/papers/29526830PubMed
28983668YC-1 alleviates bone loss in ovariectomized rats by inhibiting bone resorption and inducing extrinsic apoptosis in osteoclasts.J Bone Miner Metab2018https://conductscience.org/library/papers/28983668PubMed

See all 66 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1664645

GET https://conductscience.org/api/papers/v1/1664645/cited_by?page=2